Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-25
2005-10-25
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S174000, C546S175000, C546S177000
Reexamination Certificate
active
06958349
ABSTRACT:
This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.
REFERENCES:
patent: 6211196 (2001-04-01), Heitsch et al.
patent: 6344462 (2002-02-01), Oku et al.
patent: 6500831 (2002-12-01), Sharif
patent: 6509468 (2003-01-01), Ohnishi et al.
patent: 0 596 406 (1994-05-01), None
patent: 0 622 361 (1994-11-01), None
patent: 0 796 848 (1997-09-01), None
patent: WO 97/11069 (1997-03-01), None
patent: WO 99/13871 (1999-03-01), None
Abe, J Med Chem, vol 41, pp. 4062-4079, 1998.
Carson John R.
Jetter Michele C.
Lee Jung S.
Youngman Mark A.
Ortho-McNeil Pharmaceuticals, Inc.
Seaman D. Margaret
LandOfFree
Heteroaryl alkylamide derivatives useful as bradykinin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl alkylamide derivatives useful as bradykinin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl alkylamide derivatives useful as bradykinin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441621